Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Closed
Net new
Funds Holding
3,541
Funds Holding Change
-27
Funds Holding Growth
-0.8%
Value
$1.1T
Holding in Top 10
1,154
Top 10 Change
-88
Top 10 Growth
-7%
Value Growth
-0.7%
New
97
Increased
1,556
Reduced
1,695
Closed
79
Capital Inflow
$43.9B
Capital Outflow
$30.3B
Net Capital Flow
+$13.7B
Capital Flow Change
+$12.4B
Calls
$11.6B
Puts
$12.5B
Net Calls
-$868M
Put/Call Ratio
1.07